Keloid Scar Injection Treatment: Steroid vs Alternative Options

Essential Insights: Maximising Keloid Treatment Success

• Keloid scars result from excessive collagen production during wound healing and are more common in individuals with darker skin tones, particularly between ages 10-30.
• Corticosteroid injections, especially triamcinolone acetonide (10-40 mg/ml), remain the gold standard treatment, working by suppressing inflammation and reducing fibroblast activity.
• Most patients require 3-6 treatment sessions spaced 3-4 weeks apart, with visible improvements beginning after 1-2 injections and optimal results typically achieved within 4-6 months.
• Alternative injection options include 5-Fluorouracil, bleomycin, verapamil, and botulinum toxin, which may be beneficial for steroid-resistant keloids.
• Combination approaches, particularly steroid injections with cryotherapy or 5-FU, significantly improve outcomes and reduce recurrence rates compared to single-modality treatments.
• Proper aftercare, including silicone therapy and sun protection, is essential for maximising treatment effectiveness and preventing keloid recurrence.
• Early professional intervention yields better results, with treatments initiated within 6-12 months of keloid formation showing higher success rates.

Table of Contents

• Understanding Keloid Scars: Causes and Characteristics
• How Do Steroid Injections Work for Keloid Treatment?
• Triamcinolone Injections: The Gold Standard for Keloids
• What Results Can You Expect from Keloid Steroid Therapy?
• Beyond Steroids: Alternative Keloid Injection Options
• Combining Treatments for Enhanced Keloid Reduction
• Recovery and Aftercare Following Keloid Injections
• When to Seek Professional Keloid Treatment in London

Understanding Keloid Scars: Causes and Characteristics

Keloid scars represent an abnormal healing response where scar tissue grows excessively beyond the boundaries of the original wound. Unlike normal scars that gradually fade, keloids continue to grow and can become significantly larger than the initial injury. These raised, firm growths typically appear reddish-purple to pink in colour and may feel itchy, tender, or painful.

The development of keloids stems from an overproduction of collagen during the wound healing process. When skin is injured, fibroblast cells produce collagen to repair the damage. In keloid formation, these cells continue producing collagen long after the wound has healed, resulting in an overgrowth of scar tissue.

Several factors increase the likelihood of developing keloids:

• Genetic predisposition (family history of keloids)
• Ethnicity (more common in individuals with darker skin tones, particularly those of African, Asian, or Hispanic descent)
• Age (most prevalent between ages 10-30)
• Hormonal factors (often develop during puberty or pregnancy)
• Location (commonly appear on earlobes, shoulders, chest, and upper back)

Keloids can form following various skin traumas including surgical incisions, ear piercings, acne, burns, or even minor scratches. Unlike hypertrophic scars which remain within the boundaries of the original wound, keloids characteristically extend beyond these borders, sometimes growing for years and rarely regressing without intervention.

How Do Steroid Injections Work for Keloid Treatment?

Corticosteroid injections represent the first-line treatment for keloid scars, with intralesional steroid therapy being the most common approach. These injections work through multiple mechanisms to address the underlying causes of keloid formation and reduce their appearance.

The primary action of steroid injections is to suppress inflammation within the keloid tissue. Corticosteroids inhibit the production of inflammatory mediators and reduce the activity of fibroblasts—the cells responsible for collagen production. By decreasing fibroblast proliferation and collagen synthesis, steroids effectively interrupt the cycle of excessive scar formation that characterises keloids.

Additionally, corticosteroid injections:

• Decrease the production of glycosaminoglycans, substances that contribute to keloid bulk
• Increase collagen degradation by enhancing collagenase activity
• Reduce vascularity within the keloid, diminishing its reddish appearance
• Suppress mast cells that contribute to itching and discomfort

The procedure involves directly injecting the steroid solution into the keloid tissue using a fine needle. The injection is typically administered at multiple points throughout the keloid to ensure even distribution of the medication. Most patients require a series of injections spaced 3-4 weeks apart, with the exact number depending on the keloid’s size, location, and response to treatment.

While mild discomfort during the procedure is common, many practitioners use topical anaesthetics or cooling techniques to minimise pain. The entire process typically takes only a few minutes per session, making it a convenient outpatient treatment for keloid management.

Triamcinolone Injections: The Gold Standard for Keloids

Triamcinolone acetonide has established itself as the gold standard corticosteroid for keloid treatment, with decades of clinical evidence supporting its efficacy. This synthetic corticosteroid is specifically formulated for intralesional injection and delivers potent anti-inflammatory effects directly to the keloid tissue.

Typically administered as triamcinolone acetonide suspension (10-40 mg/ml), the concentration is carefully selected based on the keloid’s characteristics. Smaller, newer keloids often respond to lower concentrations, while larger, more established keloids may require higher dosages. The precise concentration is determined by the treating dermatologist based on factors including:

• Keloid size, thickness, and age
• Location on the body
• Patient’s skin type
• Previous treatment responses

Triamcinolone’s effectiveness stems from its superior tissue penetration and prolonged activity within the keloid. Once injected, the medication remains active in the tissue for several weeks, providing sustained suppression of the inflammatory and fibrotic processes driving keloid formation.

Clinical studies consistently demonstrate that triamcinolone injections can achieve significant flattening in 50-100% of keloids, with best results seen when treatment begins early. A comprehensive approach to keloid management typically involves multiple triamcinolone sessions, with most patients requiring 3-6 treatments to achieve optimal results.

While highly effective, triamcinolone therapy requires expertise in proper injection technique. The medication must be delivered precisely into the keloid tissue rather than surrounding healthy skin to maximise benefits and minimise potential side effects such as skin atrophy or pigmentation changes.

What Results Can You Expect from Keloid Steroid Therapy?

Patients undergoing keloid steroid therapy can anticipate progressive improvement across multiple treatment sessions, though individual responses vary based on several factors. Understanding realistic expectations helps patients navigate their treatment journey with appropriate timelines and outcomes in mind.

Most patients begin noticing changes after their first or second injection, with initial improvements typically including:

• Reduction in itching and discomfort (often within days)
• Decreased redness and inflammation
• Softening of the keloid texture
• Subtle flattening of the raised tissue

The full benefits of corticosteroid scar treatment develop gradually over time. Research indicates that approximately 70-80% of patients experience significant flattening of their keloids after a complete course of treatment. The degree of improvement varies, with factors such as keloid age, size, and location influencing outcomes. Newer, smaller keloids typically respond more favourably than older, larger ones.

The timeline for visible results generally follows this pattern:

• 1-2 weeks: Reduction in symptoms (itching, tenderness)
• 3-4 weeks: Noticeable softening and initial flattening
• 2-3 months: Significant reduction in size and prominence
• 4-6 months: Maximum improvement (after completing full treatment course)

While steroid injections can dramatically improve keloid appearance, it’s important to note that complete elimination is not always achievable. Additionally, keloid recurrence remains a possibility, with studies suggesting recurrence rates of 9-50% following steroid therapy alone. This highlights the importance of maintenance treatments and combination approaches for long-term management of keloid scars.

Beyond Steroids: Alternative Keloid Injection Options

While corticosteroid injections remain the mainstay of keloid treatment, several alternative injection therapies have emerged for patients who don’t respond adequately to steroids or experience unwanted side effects. These innovative approaches target different aspects of keloid formation and can be particularly valuable in resistant cases.

5-Fluorouracil (5-FU) injections represent one of the most promising alternatives. This antimetabolite works by inhibiting fibroblast proliferation and collagen synthesis. Studies show that intralesional 5-FU, either alone or combined with corticosteroids, can achieve significant keloid reduction with potentially fewer side effects than steroids alone. The typical protocol involves weekly injections for 8-12 weeks, with response rates of 45-78% reported in clinical trials.

Bleomycin, an antitumour agent, has demonstrated effectiveness in keloid management through its ability to induce cellular apoptosis and inhibit collagen synthesis. Administered via multiple puncture technique or intralesional injection, bleomycin typically requires 2-6 sessions at monthly intervals. Research indicates complete flattening in approximately 73% of cases, with partial response in an additional 21%.

Other alternative injection options include:

• Verapamil: A calcium channel blocker that increases collagenase activity
• Interferon: Reduces collagen production and fibroblast proliferation
• Botulinum toxin: May reduce tension across wounds and inhibit fibroblast activity
• Mitomycin C: An antitumour antibiotic that suppresses fibroblast proliferation

Autologous fat grafting represents an emerging biological approach, where the patient’s own processed fat tissue is injected into the keloid. This technique may help normalise the wound environment and promote healthier remodelling of scar tissue.

Each alternative carries its own risk-benefit profile, and selection depends on factors including keloid characteristics, previous treatment responses, and patient preferences. Consultation with a keloid specialist is essential to determine the most appropriate option for individual cases.

Combining Treatments for Enhanced Keloid Reduction

The complex nature of keloid formation often necessitates a multimodal approach to treatment. Combining different therapeutic modalities can target multiple aspects of keloid pathophysiology simultaneously, potentially yielding superior outcomes compared to monotherapy. This integrated strategy has become increasingly favoured by keloid specialists seeking to maximise results and minimise recurrence.

One of the most effective combination approaches pairs intralesional steroid injections with cryotherapy. The cryotherapy temporarily damages keloid tissue and increases its permeability, allowing for enhanced penetration and distribution of subsequently injected steroids. Studies demonstrate that this combination can achieve up to 84% reduction in keloid volume, significantly outperforming either treatment alone.

Other powerful combination strategies include:

• Steroid + 5-FU injections: This pairing combines the anti-inflammatory effects of steroids with 5-FU’s ability to inhibit fibroblast proliferation. Research indicates this combination may reduce recurrence rates to as low as 19%, compared to 50% with steroids alone.
• Injections + silicone therapy: Following injection treatments, the application of silicone sheets or gel provides continuous pressure and occlusion, helping to maintain results and prevent recurrence.
• Injections + laser therapy: Pulsed dye laser or fractional CO2 laser treatments can complement injections by targeting vascularity and promoting collagen remodelling.
• Surgery + adjuvant injections: For select cases, surgical excision followed by prophylactic steroid injections may be appropriate, though this approach requires careful patient selection.

The timing and sequencing of combined treatments is crucial for optimising outcomes. Typically, more aggressive interventions are performed first, followed by maintenance therapies. Treatment plans are customised based on keloid characteristics, previous treatment history, and individual risk factors for recurrence.

While combination approaches often yield superior results, they may also carry increased risk of side effects. Careful monitoring by experienced practitioners is essential to balance efficacy with safety throughout the treatment course.

Recovery and Aftercare Following Keloid Injections

Proper aftercare following keloid injections plays a crucial role in maximising treatment efficacy and minimising potential complications. While injection therapy is minimally invasive, specific post-treatment care helps optimise healing and long-term outcomes.

Immediately after receiving keloid injections, patients may experience temporary side effects including:

• Mild pain or discomfort at the injection site
• Localised swelling or bruising
• Temporary skin depression at injection points
• Slight bleeding or fluid discharge

These reactions typically resolve within 24-48 hours without specific intervention. Applying cold compresses for 10-15 minutes several times during the first day can help reduce discomfort and swelling. Patients may take paracetamol if needed, but should avoid aspirin and NSAIDs for 48 hours as these may increase bruising.

For optimal recovery and results, patients should follow these aftercare guidelines:

• Keep the treated area clean and dry for 24 hours
• Avoid touching, scratching, or picking at the injection sites
• Apply prescribed topical treatments as directed
• Use silicone sheets or gel if recommended by your specialist
• Protect the area from sun exposure with SPF 50+ sunscreen
• Avoid strenuous activities that might stretch or irritate the treated area for 48 hours

Long-term aftercare involves consistent use of maintenance therapies such as silicone products, pressure therapy, or topical treatments as prescribed. Regular follow-up appointments are essential for monitoring progress and adjusting treatment plans as needed.

Patients should promptly report any concerning symptoms including excessive pain, spreading redness, increased swelling after 48 hours, discharge, or fever, as these may indicate infection requiring medical attention. Additionally, any significant skin changes such as persistent paleness, depression, or textural changes should be discussed with your specialist at your next appointment.

When to Seek Professional Keloid Treatment in London

Determining the right time to consult a specialist for keloid treatment can significantly impact treatment outcomes. While small, asymptomatic keloids might not require immediate intervention, several indicators suggest professional treatment would be beneficial.

Consider seeking specialist care when your keloid:

• Causes persistent pain, itching, or discomfort
• Continues to grow or expand beyond the original wound boundaries
• Restricts movement or affects functionality
• Causes psychological distress or impacts self-confidence
• Has not responded to over-the-counter treatments
• Shows signs of infection (increased redness, warmth, tenderness)

Early intervention typically yields better results, particularly for newly formed keloids that haven’t fully matured. Research indicates that treatment initiated within the first 6-12 months of